BOC Sciences - Products
London
BOC Sciences provides various research (bio)chemicals: inhibitors, building blocks, carbohydrates, nucleosides, nucleotides, GMP Products, impurities, metabolites, APIs, natural compounds, ADCs, and chiral compounds.
| Product | Description | |
|---|---|---|
| BMS 986020 | BMS 986020 is a high-affinity lysophosphatidic acid receptor 1 (LPA1) antagonist with an IC50 value less than 300 nM for human LPA1 expressing CHO cells. It inhibits bile acid and phospholipid transporters with IC50s of 4.8 μM, 6.2 μM, and 7.5 μM for BSEP, MRP4, and MDR3, respectively. BMS 986020 is used for the treatment of idiopathic pulmonary fibrosis (IPF). Group: Pharmaceutical. CAS No. 1257213-50-5. Pack Sizes: 100 mg. Product ID: B2693-292060. Molecular formula: Custom synthesis is available. Send your inquiries for more information. |  London |
| BMS-986120 | BMS-986120, an imidazoles derivative, has been found to be a PAR4 antagonist that could probably be effective against thrombus propagation and pathological vascular occlusion. It was just completed a Phase I trail in in Thrombosis. Group: Pharmaceutical. CAS No. 1478712-37-6. Pack Sizes: 500 mg. Product ID: B2693-475816. Molecular formula: Custom synthesis is available. Send your inquiries for more information. | London |
| BMS-986141 | BMS-986141 is a potential medication under the clinical trial that evaluates the pharmacokinetics of BMS-986141 in participants with hepatic impairment compared to healthy participants. Group: Pharmaceutical. CAS No. 1478711-48-6. Pack Sizes: 100 mg. Product ID: B2693-007746. Molecular formula: Custom synthesis is available. Send your inquiries for more information. | London |
| BMS-986165 | BMS-986165 is a potent and selective TYK2 inhibitor that blocks signal transduction of IL-23, IL-12, and type I IFNs. It binds to the Tyk2 pseudokinase domain (Ki = 0.02 nM), and is highly selective against a panel of 265 kinases and pseudokinases. BMS-986165 is under a phase III clinical trial for the treatment of Psoriasis. Group: Pharmaceutical. CAS No. 1609392-27-9. Pack Sizes: 100 mg. Product ID: B2702-292590. Molecular formula: Custom synthesis is available. Send your inquiries for more information. | London |
| BMS-986195 | BMS-986195 is a Bruton's tyrosine kinase (BTK) inhibitor with IC50 of 0.1 nM. Group: Pharmaceutical. CAS No. 1912445-55-6. Pack Sizes: 200 mg. Product ID: B1370-057810. Molecular formula: Custom synthesis is available. Send your inquiries for more information. | London |
| Boc-aminooxyacetic acid | A Boc-protected bifunctional linking reagent. Group: Pharmaceutical. CAS No. 42989-85-5. Pack Sizes: 100 g. Product ID: BAT-001343. Molecular formula: Custom synthesis is available. Send your inquiries for more information. | London |
| Boc-β-tert-butyl-L-alanine | Boc-β-tert-butyl-L-alanine. Group: Pharmaceutical. CAS No. 79777-82-5. Pack Sizes: 2.5 g. Product ID: BAT-007191. Molecular formula: Custom synthesis is available. Send your inquiries for more information. | London |
| Boc-D-FMK | BOC-D-FMK is a cell-permeable broad-spectrum caspase inhibitor that fully inhibits the pro-apoptotic effect of tumor necrosis factor-α (TNFα). It has been found to reduce the activation of nuclear factor kappa light chain enhancer of activated B cells (NF-kB), suppress the phosphorylation of subunit nuclear factor kappa light polypeptide gene enhancer in B cells inhibitor α (IkBα) and inhibit TNF-induced expression of intercellular adhesion molecule 1 (ICAM-1) and vascular cell adhesion molecule 1 (VCAM-1). Moreover, it has also effectively attenuated the hepatocyte apoptosis in bile duct-ligated rats potentially improving the survival rates. Uses: Caspase inhibitors. Group: Pharmaceutical. CAS No. 187389-53-3. Pack Sizes: 100 mg. Product ID: BAT-010386. Molecular formula: Custom synthesis is available. Send your inquiries for more information. | London |
| Boc-D-Phe-Phe | Boc-D-Phe-Phe. Group: Pharmaceutical. CAS No. 125511-90-2. Pack Sizes: 1 g. Product ID: BAT-016476. Molecular formula: Custom synthesis is available. Send your inquiries for more information. | London |
| Boc-GRR-AMC TFA | Boc-GRR-AMC (TFA) is a tri-peptide Substrate. BOC-GRR-AMC is cleaved by type II Metacaspases Atmc4 and Atmc9 of Arabidopsis thaliana. It is a substrate for flavivirus proteases such as West Nile virus protease, yellow fever virus NS3 protease, and dengue virus NS2B-NS3 protease. Group: Pharmaceutical. Pack Sizes: 100 mg. Product ID: BAT-016508. Molecular formula: Custom synthesis is available. Send your inquiries for more information. | London |
| Boc-His(Trt)-Aib-OH | Boc-His(Trt)-Aib-OH, a highly specialized peptide synthesis reagent employed within the biomedical industry, presents a powerful capability for the creation of peptide sequences inclusive of unconventional amino acids. Its steadfast utilization helps to promote the generation of distinct and optimal peptide architectures, critical for the progression of targeted drug development, including the likes of Alzheimer's disease, cancer and many other diseases. Group: Pharmaceutical. CAS No. 2061897-68-3. Pack Sizes: 5 g. Product ID: BAT-000828. Molecular formula: Custom synthesis is available. Send your inquiries for more information. | London |
| Boc-L-beta-homoalanine | Boc-L-beta-homoalanine, a noteworthy derivative of beta-homoalanine, serves as an essential constituent in the production of peptides and mimics. Its effectivity as a medicinal substance, especially with reference to treating devastating afflictions like Parkinson's, Alzheimer's, and multiple sclerosis, has been the focal point of discussion in relevant studies. Group: Pharmaceutical. CAS No. 158851-30-0. Pack Sizes: 50 g. Product ID: BAT-010847. Molecular formula: Custom synthesis is available. Send your inquiries for more information. | London |
| Boc-LRR-AMC (trifluoroacetate salt) | Boc-LRR-AMC is a fluorogenic substrate for the trypsin-like activity of the 26S proteasome or 20S proteolytic core. Group: Pharmaceutical. Pack Sizes: 50 mg. Product ID: BAT-016477. Molecular formula: Custom synthesis is available. Send your inquiries for more information. | London |
| Boc-L-Valinal | Boc-L-Valinal. Group: Pharmaceutical. CAS No. 79069-51-5. Pack Sizes: 5 g. Product ID: BAT-000744. Molecular formula: Custom synthesis is available. Send your inquiries for more information. | London |
| Boc-Saxagliptin | An impurity of saxagliptin. Saxagliptin is a dipeptidyl peptidase-4 (DPP-4) inhibitor for the treatment of type II diabetes. Group: Pharmaceutical. CAS No. 709031-43-6. Pack Sizes: 25 mg. Product ID: B1370-149516. Molecular formula: Custom synthesis is available. Send your inquiries for more information. | London |
| Boc-Val-Cit-PAB-PNP | Boc-Val-Cit-PAB-PNP. Group: Pharmaceutical. CAS No. 870487-10-8. Pack Sizes: 1 g. Product ID: BADC-00698. Molecular formula: Custom synthesis is available. Send your inquiries for more information. | London |
| BOC-VAL-PRO-ARG-MCA TFA salt | BOC-VAL-PRO-ARG-MCA is a specific, highly fluorogenic substrate for thrombin and the thrombin-staphylocoagulase complex. Group: Pharmaceutical. Pack Sizes: 5 mg. Product ID: BAT-016101. Molecular formula: Custom synthesis is available. Send your inquiries for more information. | London |
| BODIPY 493/503 carboxylic acid | BODIPY 493/503 carboxylic acid. Group: Pharmaceutical. CAS No. 216961-95-4. Pack Sizes: 500 mg. Product ID: F01-0254. Molecular formula: Custom synthesis is available. Send your inquiries for more information. | London |
| BODIPY 493/503 NHS Ester | BODIPY 493/503 NHS Ester is a green-fluorescent dye that is reactive with primary amines on peptides, proteins, modified nucleotides, biopolymers, and other amine-containing biomolecules. This compound is relatively insensitive to environment and pH changes. Group: Pharmaceutical. CAS No. 216961-98-7. Pack Sizes: 100 mg. Product ID: B1370-285334. Molecular formula: Custom synthesis is available. Send your inquiries for more information. | London |
| BODIPY 576/589 | BODIPY 576/589 is a biological labeled dye. Group: Pharmaceutical. CAS No. 150173-78-7. Pack Sizes: 100 mg. Product ID: F01-0251. Molecular formula: Custom synthesis is available. Send your inquiries for more information. | London |
| BODIPY Green 8-P2M | BODIPY Green 8-P2M is a thiol-reactive, green-fluorescent dye, and it is relatively selective for reaction with thiol groups when reacted at pH below 7.5. Group: Pharmaceutical. CAS No. 929679-22-1. Pack Sizes: 100 mg. Product ID: B1370-285921. Molecular formula: Custom synthesis is available. Send your inquiries for more information. | London |
| Boehmenan | Boehmenan is a natural lignan found in the herbs of Euphorbia hirta Linn, it inhibits PTP1B activity in a competitive manner and may also inhibit the Wnt signal by decreasing β-catenin levels. Group: Pharmaceutical. CAS No. 57296-22-7. Pack Sizes: 1 mg. Product ID: NP3915. Molecular formula: Custom synthesis is available. Send your inquiries for more information. | London |
| Boeravinone B | Boeravinone B isolated from the roots of Boerhaavia coccinea. Group: Pharmaceutical. CAS No. 114567-34-9. Pack Sizes: 1 mg. Product ID: NP2249. Molecular formula: Custom synthesis is available. Send your inquiries for more information. | London |
| Bombesin | Bombesin is a neuropeptide with many biological effects such as hormone release, activation of pancreatic enzyme secretion, inhibition of gastric emptying and modulation of gastric acid secretion. It binds to the gastrin-releasing peptide receptor (GRPR) in rat pancreatic acinar cells (Ki = 1.88 nM), and also to frog bombesin receptor subtype 4 (BB4) in CHO cells overexpressing the receptor (Ki = 1.7 nM). Uses: Neurotransmitter agents. Group: Pharmaceutical. CAS No. 31362-50-2. Pack Sizes: 10 mg. Product ID: BAT-006169. Molecular formula: Custom synthesis is available. Send your inquiries for more information. | London |
| Bonducellin | Bonducellin is isolated from the herbs of Caesalpinia spinosa. Bonducellin shows weak antiproliferative against A2780 human ovarian cancer cell line with the IC50 value of 10.6 uM. Bonducellin has anti-inflammatory activities that can significantly and dose-dependently inhibit the inflammatory mediators: nitric oxide (NO), and cytokines [tumor necrosis factor (TNF)-alpha and interleukin (IL)-12]. Bonducellin shows modulation in the MIC of EtBr by eight fold at a concentration of 62.5 mg/L and also shows significant efflux pump inhibitory activity. Group: Pharmaceutical. CAS No. 83162-84-9. Pack Sizes: 2 mg. Product ID: NP2129. Molecular formula: Custom synthesis is available. Send your inquiries for more information. | London |
| Bonducellpin D | Bonducellpin D is a natural diterpenoid compound found in several plants. Group: Pharmaceutical. CAS No. 197781-85-4. Pack Sizes: 1 mg. Product ID: NP1225. Molecular formula: Custom synthesis is available. Send your inquiries for more information. | London |
| Borapetoside B | Borapetoside B is isolated from Tinospora. Uses: Hypoglycemic. Group: Pharmaceutical. CAS No. 104901-05-5. Pack Sizes: 5 mg. Product ID: NP1440. Molecular formula: Custom synthesis is available. Send your inquiries for more information. | London |
| Borapetoside E | Borapetoside E is isolated from Tinospora. Group: Pharmaceutical. CAS No. 151200-49-6. Pack Sizes: 1 mg. Product ID: NP1218. Molecular formula: Custom synthesis is available. Send your inquiries for more information. | London |
| Borapetoside F | Borapetoside F is isolated from Tinospora. Group: Pharmaceutical. CAS No. 151200-50-9. Pack Sizes: 1 mg. Product ID: NP1219. Molecular formula: Custom synthesis is available. Send your inquiries for more information. | London |
| Bornaprine Impurities | Bornaprine Impurities, crucial constituents in pharmaceutics, are instrumental for assessing Bornaprine formulation purity and stability. These impurities, impacting drug efficacy and safety, necessitate meticulous identification and quantification. Such analytical precision is paramount in quality control, particularly for therapeutics addressing muscle spasticity and associated neurological disorders. Group: Pharmaceutical. Pack Sizes: 1mg; 1g; 10g. Molecular formula: Custom synthesis is available. Send your inquiries for more information. | London |
| Borneol 7-O-[β-D-apiofuranosyl-(1?6)]-β-D-glucopyranoside | A monoterpenoid glycoside isolated from the roots of Radix ophiopogonis. A constituent of Shengmai injection. Group: Pharmaceutical. CAS No. 88700-35-0. Pack Sizes: 5 mg. Product ID: B0005-053783. Molecular formula: Custom synthesis is available. Send your inquiries for more information. | London |
| Bortezomib | Bortezomib is a potent, reversible and selective 20S proteasome inhibitor with a Ki of 0.6 nM. It is an antineoplastic agent that is used in treatment of refractory multiple myeloma and certain lymphomas. Group: Pharmaceutical. CAS No. 179324-69-7. Pack Sizes: 1 g. Product ID: BBF-05860. Molecular formula: Custom synthesis is available. Send your inquiries for more information. | London |
| Bortezomib Impurities | Bortezomib Impurities hold paramount importance in biomedical research, serving as key indicators for assessing degradation and stability profiles of the proteasome inhibitor Bortezomib. Their analysis aids scientists in determining drug purity and efficacy, thereby facilitating advancements in therapeutic strategies, particularly for multiple myeloma and specific lymphomas. Group: Pharmaceutical. Pack Sizes: 1mg; 1g; 10g. Molecular formula: Custom synthesis is available. Send your inquiries for more information. | London |
| Bortezomib Impurity (R,R-Isomer) | Bortezomib Impurity (R,R-Isomer) is a diastereomer of Bortezomib. Group: Pharmaceutical. CAS No. 1132709-15-9. Pack Sizes: 25 mg. Product ID: B2694-467634. Molecular formula: Custom synthesis is available. Send your inquiries for more information. | London |
| Bortezomib Impurity (R,S-Isomer) | Bortezomib Impurity (R,S-Isomer) is a diastereomer of Bortezomib. Group: Pharmaceutical. CAS No. 1132709-16-0. Pack Sizes: 50 mg. Product ID: B2694-467635. Molecular formula: Custom synthesis is available. Send your inquiries for more information. | London |
| Bortezomib USP Impurity G | Bortezomib USP Impurity G is an isomer of Bortezomib. It has been demonstrated to inhibit serine proteases shown to lower cellular Aβ concentrations, associated with Alzheimer's or hypertension. Group: Pharmaceutical. CAS No. 1132709-14-8. Pack Sizes: 10 mg. Product ID: B0103-467636. Molecular formula: Custom synthesis is available. Send your inquiries for more information. | London |
| Boscalid | Boscalid is a fungicide belonging to the class of carboxamides. It has been used in agriculture to protect crops. Group: Pharmaceutical. CAS No. 188425-85-6. Pack Sizes: 5 g. Product ID: B2692-010570. Molecular formula: Custom synthesis is available. Send your inquiries for more information. | London |
| Bosentan Impurities | Bosentan Impurities, crucial components in pharmaceutical analysis, play an indispensable role in the meticulous assessment of Bosentan's therapeutic efficacy against pulmonary arterial hypertension. They act as vital markers for evaluating stability, pharmacokinetics, and adverse effects, thereby ensuring the safety and success of drug formulation during stringent regulatory scrutiny. Group: Pharmaceutical. Pack Sizes: 1mg; 1g; 10g. Molecular formula: Custom synthesis is available. Send your inquiries for more information. | London |
| Bosutinib | Bosutinib (SKI-606) is a novel, dual Src/Abl inhibitor with IC50 of 1.2 nM and 1 nM, respectively. Group: Pharmaceutical. CAS No. 380843-75-4. Pack Sizes: 1 g. Product ID: B2693-067595. Molecular formula: Custom synthesis is available. Send your inquiries for more information. | London |
| Bosutinib Impurities | Bosutinib Impurities, essential in the sphere of pharmaceutical innovation, are integral to confirming the stability and safety profile of Bosutinib, a therapeutic agent for chronic myeloid leukemia. These impurities underpin drug quality assurance, enabling therapeutic efficacy and adherence to regulatory standards, thus safeguarding the drug's lifecycle continuity amidst stringent criteria. Group: Pharmaceutical. Pack Sizes: 1mg; 1g; 10g. Molecular formula: Custom synthesis is available. Send your inquiries for more information. | London |
| Boswellic acid | α-Boswellic acid, a pentacyclic triterpene molecule, is isolated from the herbs of Boswellia carterii Birdw. Nutritional supplement in health care products. Uses: Ingredient of health care products. Group: Pharmaceutical. CAS No. 471-66-9. Pack Sizes: 10 mg. Product ID: NP6249. Molecular formula: Custom synthesis is available. Send your inquiries for more information. | London |
| BPC 157 | BPC-157 is a synthetic pentadecapeptide. Study shows that BPC-157 is beneficial for the treatment of ulcers in the stomach, intestinal damage such as fistulas and inflammatory disorders, bone and joint healing and growth rates, and organ damage. Uses: bpc-157, short for body protection compound-157, is a synthetic peptide derived from a small protein found in the stomach called bpc. it has attracted great interest in the field of drug discovery due to its promising therapeutic potential in various medical conditions. this peptide has been studied for its wound healing properties, tissue repair capabilities, anti-inflammatory effects, and pot. Group: Pharmaceutical. CAS No. 137525-51-0. Pack Sizes: 10 mg. Product ID: BAT-010081. Molecular formula: Custom synthesis is available. Send your inquiries for more information. | London |
| BQU57 | BQU57, a derivative of RBC8, is a selective GTPase Ral inhibitor relative to the GTPases Ras and RhoA. Group: Pharmaceutical. CAS No. 1637739-82-2. Pack Sizes: 50 mg. Product ID: B0084-463448. Molecular formula: Custom synthesis is available. Send your inquiries for more information. | London |
| Brain natriuretic peptide | A brain natriuretic peptide secreted by the human heart in response to cardiac volume or pressure. Group: Pharmaceutical. CAS No. 114471-18-0. Pack Sizes: 1 mg. Product ID: BAT-006199. Molecular formula: Custom synthesis is available. Send your inquiries for more information. | London |
| Brandioside | Brandioside is found in the herbs of Verbena officinalis. Brandioside exhibits inhibitory effect on advanced glycation end product formation and smooth muscle cell proliferation. Group: Pharmaceutical. CAS No. 133393-81-4. Pack Sizes: 5 mg. Product ID: B0005-053779. Molecular formula: Custom synthesis is available. Send your inquiries for more information. | London |
| BRD 4354 | BRD 4354 is an HDAC5 and HDAC9 inhibitor (IC50 = 0.85 and 1.88 μM, respectively) displaying >20-fold selectivity for HDAC5/9 over HDAC1/2/3. It also weakly inhibits HDAC4, HDAC6, HDAC7 and HDAC8 (IC50 values are 3.88 - 13.8 μM). Group: Pharmaceutical. CAS No. 315698-07-8. Pack Sizes: 50 mg. Product ID: B2693-119062. Molecular formula: Custom synthesis is available. Send your inquiries for more information. | London |
| Brefeldin A | Brefeldin is an antibiotic produced by Penicillum brefeldianum S-464, Pen. cyaneum S-ll, Pen. decumbens, Pen. simplicissimum S-543, etc. Brefeldin A has anti-candida, aspergillus and anti-tumor activity. Uses: Antiviral agents. Group: Pharmaceutical. CAS No. 20350-15-6. Pack Sizes: 100 mg. Product ID: BBF-00586. Molecular formula: Custom synthesis is available. Send your inquiries for more information. | London |
| Bremelanotide | Bremelanotide is a peptide melanocortin receptor agonist developed for the treatment of sexual dysfunction, hemorrhagic shock and reperfusion injury. Uses: bremelanotide is a synthetic peptide drug that has generated a lot of interest in the drug development community due to its potential applications in sexual dysfunction and other conditions. this peptide is a synthetic analog of the natural hormone alpha-msh (melanocyte stimulating hormone) and acts as a non-selective agonist of the melanocortin receptors mc3-r and mc4-r. one of the main areas. Group: Pharmaceutical. CAS No. 189691-06-3. Pack Sizes: 10 mg. Product ID: BAT-010024. Molecular formula: Custom synthesis is available. Send your inquiries for more information. | London |
| Brequinar sodium | Brequinar sodium is a potent and selective dihydroorotate dehydrogenase (DHODH) inhibitor (IC50 = ~20 nM), which causes the blockade of de novo pyrimidine nucleotide biosynthesis. Uses: Antineoplastic agents. Group: Pharmaceutical. CAS No. 96201-88-6. Pack Sizes: 50 mg. Product ID: B2693-305415. Molecular formula: Custom synthesis is available. Send your inquiries for more information. | London |
| Brevianamide F | Brevianamide F, belongs to a class of naturally occurring 2,5-diketopiperazines, is produced by the fungi A.fumigates and Aspergillus sp. Group: Pharmaceutical. CAS No. 38136-70-8. Pack Sizes: 100 mg. Product ID: NP0227. Molecular formula: Custom synthesis is available. Send your inquiries for more information. | London |
| Brevilin A | Brevilin A, also called 6-O-Angeloylplenolina, is a natural sesquiterpenoid found in the herbs of Centipeda minima, it exhibits the antigiardial activity (IC50 = 16.1 μM) and is similarly active in vitro against Entamoeba histolytica (IC50 between 4.5 and 9 μM) and against Plasmodium falciparum (IC50 = 9.42 μM). Brevilin A inhibits janus kinase activity and exhibits both strong STAT3 signal inhibition and STAT3 signal dependent cell growth inhibition. Uses: Anti-giardial. Group: Pharmaceutical. CAS No. 16503-32-5. Pack Sizes: 5 mg. Product ID: NP5612. Molecular formula: Custom synthesis is available. Send your inquiries for more information. | London |
| Brexpiprazole | Brexpiprazole is a novel atypical antipsychotic drug. It is a D2 dopamine partial agonist called serotonin-dopamine activity modulator (SDAM). It is a drug candidate useful in treatment and prevention of mental disorders including CNS disorders. Uses: Brexpiprazole is approved for the treatment of schizophrenia, and as an adjunctive treatment for depression. it is a drug candidate useful in treatment and prevention of mental disorders including cns disorders. Group: Pharmaceutical. CAS No. 913611-97-9. Pack Sizes: 1 g. Product ID: B0084-474906. Molecular formula: Custom synthesis is available. Send your inquiries for more information. | London |
| Brexpiprazole Impurities | Brexpiprazole Impurities are used in the biomedical industry to analyze and ensure the purity and safety of Brexpiprazole, an antipsychotic medication primarily prescribed for schizophrenia and major depressive disorder. These impurities assist researchers and pharmaceutical companies in quality control and regulatory compliance efforts. Group: Pharmaceutical. Pack Sizes: 1mg; 1g; 10g. Molecular formula: Custom synthesis is available. Send your inquiries for more information. | London |
| Brexpiprazole Impurity 10 | Brexpiprazole Impurity 10 is an impurity of Brexpiprazole, a drug used to counter psychiatric afflictions such as schizophrenia and major depressive disorder. Group: Pharmaceutical. CAS No. 15116-41-3. Pack Sizes: 50 mg. Product ID: B0461-467695. Molecular formula: Custom synthesis is available. Send your inquiries for more information. | London |
| Brigatinib | Brigatinib, also known as AP-26113, is an orally active, potent and selective dual ALK/EGFR inhibitor. AP26113 is an orally bioavailable inhibitor of anaplastic lymphoma kinase (ALK; IC50 < 100 nM in Ba/F3 cells). AP26113 binds to and inhibits ALK kinase and ALK fusion proteins as well as EGFR and mutant forms. It blocks ALK activity and reduces growth in neuroblastoma cells, mouse xenograft, and Drosophila model systems harboring constitutively active ALK variants. Group: Pharmaceutical. CAS No. 1197953-54-0. Pack Sizes: 1 g. Product ID: B0084-470820. Molecular formula: Custom synthesis is available. Send your inquiries for more information. | London |
| Brimonidine Impurities | Brimonidine Impurities are crucial analytical standards in the biomedical arena. They facilitate the development and quality control of brimonidine formulations, primarily used for treating glaucoma and ocular hypertension. These impurities ensure drug safety and efficacy by enabling precise quantification and identification of unwanted chemical entities during pharmaceutical manufacturing. Group: Pharmaceutical. Pack Sizes: 1mg; 1g; 10g. Molecular formula: Custom synthesis is available. Send your inquiries for more information. | London |
| Brimonidine impurity II | Brimonidine impurity II is an analogue of Brimonidine. Group: Pharmaceutical. CAS No. 91147-43-2. Pack Sizes: 100 mg. Product ID: B2694-467706. Molecular formula: Custom synthesis is available. Send your inquiries for more information. | London |
| Brimonidine Related Impurity 2 | Brimonidine Related Impurity 2 is a brimonidine impurity. Group: Pharmaceutical. CAS No. 151110-15-5. Pack Sizes: 20 mg. Product ID: B0463-467714. Molecular formula: Custom synthesis is available. Send your inquiries for more information. | London |
| Brinzolamide | Brinzolamide is a potent carbonic anhydrase II inhibitor with IC50 of 3.19 nM. Uses: Carbonic anhydrase inhibitors. Group: Pharmaceutical. CAS No. 138890-62-7. Pack Sizes: 1 g. Product ID: NP3240. Molecular formula: Custom synthesis is available. Send your inquiries for more information. | London |
| Brinzolamide Impurities | Brinzolamide Impurities hold an integral role in the meticulous realm of quality control for brinzolamide, a therapeutic agent targeting elevated intraocular pressure in ocular hypertension or open-angle glaucoma. They critically ensure safety, efficacy, and stability, underpinning the entire drug development and production continuum with scientific precision. Group: Pharmaceutical. Pack Sizes: 1mg; 1g; 10g. Molecular formula: Custom synthesis is available. Send your inquiries for more information. | London |
| Brinzolamide Related Compound B | Brinzolamide Related Compound B is Brinzolamide derivative. Group: Pharmaceutical. CAS No. 404034-55-5. Pack Sizes: 100 mg. Product ID: B0464-467722. Molecular formula: Custom synthesis is available. Send your inquiries for more information. | London |
| Brinzolamide Related Compound C | Brinzolamide Related Compound C is an isomer of Brinzolamide. Group: Pharmaceutical. CAS No. 154127-19-2. Pack Sizes: 100 mg. Product ID: B0464-467726. Molecular formula: Custom synthesis is available. Send your inquiries for more information. | London |
| Britannilactone | A bioassay-guided isolation of the chloroform fraction of the I. britannica using an in vitro melanogenesis inhibition assay led to the isolation of sesquiterpenes, 1-O-acetylbritannilactone (1), britannilactone (2) and neobritannilactone B (3). Compounds 1 and 2 significantly reduced melanin production in a dose-dependent manner with IC50 values of 13.3 and 15.5 μM, respectively. Group: Pharmaceutical. CAS No. 33620-72-3. Pack Sizes: 1 mg. Product ID: NP5973. Molecular formula: Custom synthesis is available. Send your inquiries for more information. | London |
| BRITE 338733 | BRITE 338733 is a novel ATPase inhibitor. BRITE 338733 inhibits the expression of RecA in bacteria (IC50 = 4.7 μM) for the treatment of bacterial infections. Uses: A novel atpase inhibitor for the treatment of bacterial infections. Group: Pharmaceutical. CAS No. 503105-88-2. Pack Sizes: 10 mg. Product ID: B0084-483824. Molecular formula: Custom synthesis is available. Send your inquiries for more information. | London |
| Brivanib | Brivanib is the hydrolyzed form of Brivanib alaninate, which is a vascular endothelial growth factor receptor 2 (VEGFR2) inhibitor with potential antineoplastic activity. Brivanib strongly binds to and inhibits VEGFR2, a tyrosine kinase receptor expressed almost exclusively on vascular endothelial cells; inhibition of VEGFR2 may result in inhibition of tumor angiogenesis, inhibition of tumor cell growth, and tumor regression. Check for active clinical trials or closed clinical trials using this agent. Group: Pharmaceutical. CAS No. 649735-46-6. Pack Sizes: 20 mg. Product ID: B0084-146707. Molecular formula: Custom synthesis is available. Send your inquiries for more information. | London |
| Brivanib alaninate | Brivanib alaninate is the alaninate ester of a vascular endothelial growth factor receptor 2 (VEGFR2) inhibitor with potential antineoplastic activity. Brivanib strongly binds to and inhibits VEGFR2, a tyrosine kinase receptor expressed almost exclusively on vascular endothelial cells; inhibition of VEGFR2 may result in inhibition of tumor angiogenesis, inhibition of tumor cell growth, and tumor regression. Check for active clinical trials or closed clinical trials using this agent. Group: Pharmaceutical. CAS No. 649735-63-7. Pack Sizes: 10 mg. Product ID: B2693-146708. Molecular formula: Custom synthesis is available. Send your inquiries for more information. | London |
| Brivudine Impurities | Brivudine Impurities are instrumental in the pharmaceutical industry for quality control and research processes related to the antiviral drug Brivudine. These impurities aid in understanding the drug's stability, efficacy, and safety profile, particularly in its use against herpes zoster infections. Group: Pharmaceutical. Pack Sizes: 1mg; 1g; 10g. Molecular formula: Custom synthesis is available. Send your inquiries for more information. | London |
| Bromfenac Impurities | Bromfenac Impurities, essential in the pharmaceutical industry, are used as analytical standards in the quality control of Bromfenac, a non-steroidal anti-inflammatory drug. Their accurate analysis ensures therapeutic efficacy and safety in the treatment of ocular inflammation post-cataract surgery and other inflammatory eye disorders. Group: Pharmaceutical. Pack Sizes: 1mg; 1g; 10g. Molecular formula: Custom synthesis is available. Send your inquiries for more information. | London |
| Bromhexine Impurities | Bromhexine Impurities possess a critical role in the biomedical realm, serving as vital evaluators of bromhexine formulation purity. These entities advance antitussive medication development, ensuring therapeutic safety and effectiveness in addressing respiratory conditions like chronic bronchitis, thereby aiding in airway clearance therapies through meticulous scrutiny and validation processes. Group: Pharmaceutical. Pack Sizes: 1mg; 1g; 10g. Molecular formula: Custom synthesis is available. Send your inquiries for more information. | London |
| Bromhexine Related Compound 2 HCl | An impurity of Bromhexine, a mucolytic (expectorant) agent used in the treatment of respiratory disorders associated with viscid or excessive mucus. Group: Pharmaceutical. CAS No. 32193-43-4. Pack Sizes: 5 mg. Product ID: B2694-467763. Molecular formula: Custom synthesis is available. Send your inquiries for more information. | London |
Would you like to list your products on UK Chemical Suppliers?
Our database is helping our users find suppliers everyday.